-+ 0.00%
-+ 0.00%
-+ 0.00%
Sensorion Presents Gene Therapy Research at ESGCT Annual Congress
Share
Listen to the news
Sensorion Presents Gene Therapy Research at ESGCT Annual Congress
  • Sensorion will attend the European Society of Gene and Cell Therapy annual congress in Hamburg, Germany, Oct. 27–30, 2026.
  • Lise Barrot will present a poster on functional testing of GJB2 gene therapy on Oct. 28, 1:30–3:30 p.m. CET.
  • Laurent Desire will present a poster on SENS-601 gene therapy for DFNB1A hearing loss on Oct. 29, 2–4 p.m. CET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensorion SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261027451785) on October 28, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending